[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334498-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-334498-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","cip2a-induces-pkm2-tetramer-formation-and-oxidative-phosphorylation-in-non-small-cell-lung-cancer-article-open-access","CIP2A induces PKM2 tetramer formation and oxidative phosphorylation in non-small cell lung cancer - Article Open Access","","Tumor cells are often viewed as impaired in mitochondrial respiration, yet non-small cell lung cancer (NSCLC) tissues show enhanced glucose oxidation versus adjacent benign lung. Liang et al. report that CIP2A suppresses glycolysis while promoting oxidative metabolism in NSCLC cells. Mechanistically, CIP2A binds PKM2 and triggers PKM2 tetramer formation via serine 287 phosphorylation, redirecting PKM2 to mitochondria and increasing Bcl2 through threonine 69 phosphorylation. CIP2A-high tumors correlate with phosphorylated PKM2 S287, and CIP2A-targeting compounds synergize with glycolysis inhibition to restrain proliferation in vitro and in vivo.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/cip2a-induces-pkm2-tetramer-formation-and-oxidative-phosphorylation-in-non-small-cell-lung-cancer-article-open-access/334498/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/cip2a-induces-pkm2-tetramer-formation-and-oxidative-phosphorylation-in-non-small-cell-lung-cancer-article-open-access/334498.png","ImageObject",300,407,{"name":42,"@type":43},"Himbo","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-16","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does CIP2A play in NSCLC metabolism?","Question",{"text":63,"@type":64},"CIP2A inhibits glycolysis and promotes oxidative metabolism in NSCLC cells.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does CIP2A influence PKM2 and mitochondrial function?",{"text":68,"@type":64},"CIP2A binds PKM2 and induces PKM2 tetramer formation through serine 287 phosphorylation, redirecting PKM2 to the mitochondrion and promoting downstream changes in Bcl2.",{"name":70,"@type":61,"acceptedAnswer":71},"What therapeutic implication is suggested by the findings?",{"text":72,"@type":64},"Targeting CIP2A synergizes with glycolysis inhibitors to suppress NSCLC cell proliferation in vitro and in vivo.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},334498,1790012771,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","Liang et al. Cell Discovery (2024)10:13  \n[https://doi.org/10.1038/s41421-023-00633-0](https://doi.org/10.1038/s41421-023-00633-0)  \nCell Discovery  \n[www.nature.com/celldisc](www.nature.com/celldisc)  \nARTICLE Open Access  \nCIP2A induces PKM2 tetramer formation and oxidative phosphorylation in non-small cell lung cancer  \nLi-Jun Liang1,2, Fu-Ying Yang1, Di Wang1,3, Yan-Fei Zhang1,4, Hong Yu1,5, Zheng Wang1, Bei-Bei Sun1, Yu-Tao Liu1 ✉, Gui-Zhen Wang1 ✉ and Guang-Biao Zhou1 ✉  \nAbstract  \nTumor cells are usually considered defective in mitochondrial respiration, but human non-small cell lung cancer (NSCLC) tumor tissues are shown to have enhanced glucose oxidation relative to adjacent benign lung. Here, we reported that oncoprotein cancerous inhibitor of protein phosphatase 2A (CIP2A) inhibited glycolysis and promoted oxidative metabolism in NSCLC cells. CIP2A bound to pyruvate kinase M2 (PKM2) and induced the formation of PKM2 tetramer, with serine 287 as a novel phosphorylation site essential for PKM2 dimer-tetramer switching. CIP2Aredirected PKM2 to mitochondrion, leading to upregulation of Bcl2 via phosphorylating Bcl2 at threonine 69 . Clinically, CIP2A level in tumor tissues was positively correlated with the level of phosphorylated PKM2 S287 . CIP2A-targeting compounds synergized with glycolysis inhibitor in suppressing cell proliferation in vitro and in vivo. These results indicated that CIP2A facilitates oxidative phosphorylation by promoting tetrameric PKM2 formation, and targeting CIP2A and glycolysis exhibits therapeutic potentials in NSCLC.  \nIntroduction  \nCancer cells exhibit the Warburg effect (aerobic glycolysis) and are usually considered to be defective in mitochondrial respiration1,2. However, recent evidence indicates that cancer cells also retain mitochondrial respiration2,3, which enables cell proliferation3. By using intraoperative 13C-glucose infusions in vivo, human nonsmall cell lung cancer (NSCLC) tumors are shown to have enhanced glucose oxidation relative to adjacent benign lung4. Consistently, murine lung cancer tumor growth requires the electron transport chain to oxidize ubiquinol,  \nCorrespondence: Yu-Tao Liu ([liuyutao@cicams.ac.cn](liuyutao@cicams.ac.cn)) or Gui-Zhen Wang  \n([gzwang@cicams.ac.cn](gzwang@cicams.ac.cn)) or Guang-Biao Zhou ([gbzhou@cicams.ac.cn](gbzhou@cicams.ac.cn))  \n1State Key Laboratory of Molecular Oncology & Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China  \n2Department of Thoracic Surgery, Second Afﬁliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China  \nFull list of author information is available at the end of the article  \nThese authors contributed equally: Li-Jun Liang, Fu-Ying Yang, Di Wang, Yan-Fei Zhang  \nwhile lack of mitochondrial complex III in cancer cells impairs tumor growth5. KRAS-driven mouse lung tumors have increased glucose contribution to the tricarboxylic acid (TCA) cycle relative to normal lung tissue, and mitochondrial metabolism of pyruvate is essential for in vivo tumor formation6. At cellular level, lung adenocarcinoma cells exhibit signiﬁcant increases in mitochondrial complex I and complex II respiratory activity7; cholangiocarcinoma cancer stem cells (CSCs) have a more efﬁcient respiratory phenotype and depend on mitochondrial oxidative metabolism to maintain stemness8, while pancreatic cancer CSCs are dependent on oxidative phosphorylation (OXPHOS) with very limited metabolic plasticity9. Some oncoproteins, such as C-JUN, can inhibit glycolysis pathways10, while MYC and MCL1 cooperate to maintain CSC resistance to chemotherapy by increasing OXPHOS and reactive oxygen species production in triple-negative breast cancer.11 However, the roles and mechanisms of oxidative metabolism in cancer cells remain to be elucidated.  \n© The Author(s) 2023  \nOpen AccessThis arti","cbCaieav76x3NKYv","https://ap.wps.com/l/cbCaieav76x3NKYv","pdf",5916749,22,"English","# Abstract\n# Introduction","[{\"question\":\"What role does CIP2A play in NSCLC metabolism?\",\"answer\":\"CIP2A inhibits glycolysis and promotes oxidative metabolism in NSCLC cells.\"},{\"question\":\"How does CIP2A influence PKM2 and mitochondrial function?\",\"answer\":\"CIP2A binds PKM2 and induces PKM2 tetramer formation through serine 287 phosphorylation, redirecting PKM2 to the mitochondrion and promoting downstream changes in Bcl2.\"},{\"question\":\"What therapeutic implication is suggested by the findings?\",\"answer\":\"Targeting CIP2A synergizes with glycolysis inhibitors to suppress NSCLC cell proliferation in vitro and in vivo.\"}]","CIP2A induces PKM2 tetramer formation and oxidative phosphorylation in non-small cell lung cancer - Article Open Access | PDF",1790006907,55]